-
1
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
Published 2025-02-01Subjects: Get full text
Article -
2
MRTX1133 attenuates KRASG12D mutated-colorectal cancer progression through activating ferroptosis activity via METTL14/LINC02159/FOXC2 axis
Published 2025-02-01Subjects: Get full text
Article